"(The) variants are almost identical and did not change areas that our immune system typically recognise, so there shouldn't be any difference for vaccines being developed," said Maurer-Stroh.
毛雷尔-斯特罗称:“变种和原病毒大致相同,没有改变我们的免疫系统通常能识别的区域,所以研发中的疫苗对二者的效果应该不会有差别。”
【专家:新冠病毒变异后更具传染性 但是致死率可能下降了】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15